SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-08-047473
Filing Date
2008-08-14
Accepted
2008-08-14 16:54:06
Documents
6
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 v123562_10q.htm 10-Q 1121969
2 GRAPHIC chart.jpg GRAPHIC 19669
3 v123562_ex31-1.htm EX-31.1 14406
4 v123562_ex31-2.htm EX-31.2 14045
5 v123562_ex32-1.htm EX-32.1 7162
6 v123562_ex32-2.htm EX-32.2 5957
  Complete submission text file 0001144204-08-047473.txt   1192337
Mailing Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071
Business Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071 86-10-63899868
Lotus Pharmaceuticals, Inc. (Filer) CIK: 0001292087 (see all company filings)

IRS No.: 200507918 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32581 | Film No.: 081020054
SIC: 2834 Pharmaceutical Preparations